Back
Top 0.2%
23.8%
Top 0.2%
12.6%
Top 59%
9.6%
#1
6.9%
Top 2%
5.4%
Top 61%
4.5%
Top 0.9%
4.5%
Top 0.7%
4.1%
Top 47%
2.1%
Top 19%
2.1%
Top 8%
2.1%
Top 35%
2.1%
Top 8%
1.4%
Top 4%
1.0%
Top 5%
1.0%
Top 6%
0.8%
Top 13%
0.8%
Top 22%
0.8%
Top 1%
0.8%
Top 12%
0.8%
Cancer immunotherapy does not increase the risk of death by COVID-19 in melanoma patients
2020-05-21
oncology
Title + abstract only
View on medRxiv
Show abstract
BackgroundCovid-19 pandemic by the new coronavirus SARS-Cov-2 has produced devastating effects on the health care system, affecting also cancer patient care. Data about COVID-19 infection in cancer patients are scarce, and they point out a higher risk of complications due to the viral infection in this population. Moreover, cancer treatments could increase viral complications, specially those treatments based on the use of immunotherapy with checkpoints antibodies. There are no clinical data abo...
Predicted journal destinations
1
Cancers
57 training papers
2
Frontiers in Oncology
34 training papers
3
PLOS ONE
1737 training papers
4
BMC Cancer
21 training papers
5
Clinical Cancer Research
22 training papers
6
Scientific Reports
701 training papers
7
British Journal of Cancer
22 training papers
8
Cancer Medicine
17 training papers
9
BMJ Open
553 training papers
10
eLife
262 training papers
11
JAMA Network Open
125 training papers
12
Nature Communications
483 training papers
13
Frontiers in Immunology
140 training papers
14
Diagnostics
36 training papers
15
PeerJ
46 training papers
16
International Journal of Molecular Sciences
39 training papers
17
Vaccines
131 training papers
18
Frontiers in Medicine
99 training papers
19
International Journal of Cancer
18 training papers
20
Heliyon
57 training papers